throbber
wk
`Encyclopedia of
`Nutritional Supplements
`The Essential Guidefor Improving
`Your Health Naturally
`
`Michael T. Murray, N.D.
`
`
`
`PRIMA PUBLISHING
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0001
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0001
`
`

`
`Copyright © 1996 by Michael T. Murray
`
`All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means,
`electronic or mechanical, including photocopying, recording, or by any information storage or retrieval
`system, without written permission from Random House, lnc., except for the inclusion of brief quotations
`in a review.
`
`Published by Prima Publishing, Roseville, California. Member of the Crown "Publishing Group, a division
`of Random House, Inc., New York.
`
`PRIMA PUBLISHING and colophon are trademarks of Random House, Inc., registered with the United
`States Patent and Trademark Office.
`
`Warning—Disclaimer
`Prima Publishing has designed this book to provide information in regard to the subject matter covered.
`It is sold with the understanding that the publisher and the author are not liable for the misconception or
`misuse of information provided. Every effort has been made to make this book as complete and as accu-
`rate as possible. The purpose of this book is to educate. The author and Prima Publishing shall have
`neither liability nor responsibility to any person or entity with respect to any loss, damage, or injury
`caused or alleged to be caused directly or indirectly by the information contained in this book. The
`information presented herein is in no way intended as a substitute for medical counseling.
`
`Library of Congress Cataloging-in-Publication Data
`
`Murray, Michael T.
`Encyclopedia of nutritional supplements 2 the essential guide for improving your health naturally /
`Michael T. Murray.
`p.
`cm.
`Includes index.
`ISBN 0-7615-0410-9
`
`'
`
`02 03 04 DD 181716
`Printed in the United States of America
`First Edition
`
`Visit us online at www.primapublisl1ing.com
`
`/lo. 3003 R 1%‘?
`
`
`
`1. Vitamins in human nutrition——Encyclopedias. 2. Minerals in human nutrition~—~Encyclopedias.
`s 3. Dietary supp1ements—~Encyc1opedias.
`I. Title.
`QP771.M87 1996
`6l2.3'9-—dc20
`
`96-3804
`CH’
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0002
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0002
`
`

`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0003
`
`

`
`SOME PRACTICAL RECOMMENDATIONS
`
`Recommended Vitamin Intake in International Units (I.U.), Milligrams (mg-)r
`or Micrograms lincg.)
`
`
`
`
`Vitamin Comments Rangefor Adults
`
`
`
`Vitamin A (retinol)
`
`5,0 0 1_[)_
`0
`
`Vitamin A (from beta-carotene)
`Vitamin D
`
`5,000—25,000 I.U.
`100.400 LU,
`
`Vitamin E (d—alpha tocopherol)
`,
`Vitamin K (phytonadione)
`Vitamin C (ascorbic acid)
`
`100-800 I.U.
`
`60—300 mcg.
`100~l,000 mg.
`
`Women of child-bearing age
`should not take more than 2,500
`l.U. of retinol daily due to the
`possible risk of birth defects if
`they become pregnant.
`
`Elderly people in nursing homes
`living in northern latitudes
`should supplement at the high
`range.
`
`It may be I’f101‘e C0St effeCtiVe *0
`take Vitamin E separately.
`
`It may be easier to take vitamin C
`separately rather than in a mul-
`tiple formula.
`
`ants, I
`‘eader
`11-jent
`; Sup_
`
`5‘
`
`‘
`
`10-100 mg.
`Vitamin B1 (thiamin)
`10-50 mg,
`Vitamin B2 (riboflavin)
`10—1o0 mg.
`Niacin
`10.30 mg.
`Niacinamide
`25-100 mg.
`Vitamin B6 (pyridoxine)
`100-300 mcg.
`Biotin
`25-100 mg,
`Pantothenic acid
`400 mcg_
`Folic acid
`40° ‘mg’
`Vita”.“i“ B12
`all of
`10.100 mg_
`Choline
`3ple_
`10-100 mg
`Inositol
`fime,
`ts as ~”-%_”
`defi-
`1
`“Ore
`3 But
`isms
`‘3 to
`ium
`
`Free radicals have also been shown to be responsible for the initiation of many dis-
`eases, including the two biggest killers of Americans--heart disease and cancer.
`Antioxidants, in contrast, are compounds that help protect against free-radiCa1
`damage. Antioxidant nutrients like beta-carotene, selenium, Vitamin E , and Vitamin
`C are very important in protecting against the development Of heart disease, Caneer,
`and other chronic degenerative diseases. In addition, antioxidants are also thought to
`slow down the aging process.
`.
`.
`_
`_
`Based on extensive data, it appears that a combination of antioxidants will provide
`greater antioxidant protection than any single nutritional antioxidant. Therefore, in
`addition to recommending that individuals consume a diet rich in plant foods, espe-
`cially fruits and vegetables, I suggest using a combination of antioxidant nutrients
`rather than high dosages of any single antioxidant. Mixtures of antioxidant nutrients
`
`rud-
`and
`139'
`
`11
`
`Sandoz V. Eli Lilly, Exhibit 1087-0004
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0004
`
`

`
`
`
`mun-esa::m....-—
`W‘
`~
`
`-«---a.-....».--u->--»----~
`
`v-neon:
`
`umaaumawu-acnm,,,_,._____
`*“"-
`
`w«m*
`
`,.,,._,..........«....«.xm.mmsm.~u
`
`““‘g’amS°f
`
`B
`
`5
`
`ethine three
`
`Folic Acid
`
`either pan-
`
`acid mms_
`C acid and
`
`Folic acid, also known as folate, folacin, and pteroylmonoglutamate, functions
`together with vitamin B12 in many body processes. It is critical to cellular division
`because it is necessary in DNA synthesis. Without folic acid, cells do not divide prop~
`erly. Folic acid is critical to the development of the nervous system of the fetus. Defi~
`ciency of folic acid during pregnancy has been linked to several birth defects,
`including neural tube defects like spina bifida. Folic acid deficiency is also linked to
`depression, atherosclerosis, and osteoporosis.
`
`Food Sources
`
`Folic acid received its name from the Latin word folium, which means ”foliage,” be
`cause it is found in high concentrations in green leafy vegetables like kale, spinach,
`beet greens, and chard. Other good sources of folic acid include legumes, asparagus,
`broccoli, cabbage, oranges, root vegetables, and whole grains (see Table 14.1)
`
`TABLE 14.1 Folic Acid Content of Selected Foods, in Micrograms per 31/2-oz. (100-g.) Serving
`
`
`
` Yeast, brewer's
`
`..
`
`Blackeye peas
`Rice germ
`Soy flour
`Wheat germ
`Liver, beef
`Soy beans
`Wheat bran
`Kidney beans
`Mung beans
`Lima beans
`Navy beans
`Garbanzos
`Asparagus
`
`2,022
`440
`430
`425
`305
`295
`225
`195
`180
`145
`130
`125
`125
`110
`
`Lentils
`Walnuts
`Spinach, fresh
`Kale
`Filbert nuts
`Beet 8: mustard greens
`Peanuts, roasted
`Peanut butter
`Broccoli
`Barley
`Split peas
`Whole~wheat cereal
`Brussels sprouts
`Almonds
`
`.
`
`105
`77
`75
`70
`65
`60
`56
`56
`53
`50
`50
`49
`49
`45
`
`Whole—wheat flour
`Oatmeal
`Cabbage
`Dried figs
`Avocado
`Green beans
`Corn
`Coconut, fresh
`Pecans
`Mushrooms
`Dates
`Blackberries
`Orange
`
`38
`33
`32
`32
`30
`28
`28
`28
`27
`25
`25
`14
`5
`
`1 1 9
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0005
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0005
`
`

`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0006
`
`

`
`"~'.""""*"‘-\.
`
`e in
`mnslsfiggziz”
`fces are rich’
`1y prescn.
`_
`.
`P
`ad metab0'
`‘Gail
`rapidly d1-
`ll tract that
`fis, and an
`‘ ’mnia, irri~
`
`zed by en-
`1'e1Yi11g on
`ate within
`31d Status,
`- 935)’ and
`T933011 is
`_:onverted
`1”“ C0ba1-
`to? 8915-
`acid and
`' _3 signif—
`13 51 S11if-
`‘3 3 Side
`'39 IGVEIS
`
`
`
`F O L I C A C I D
`
`Micrograms
`
`Group
`YOUNG Auuus AND Aouus
`150
`Males 11-14 years
`200
`Males 15+ years
`150
`Females 11-14 years
`180
`Females 15+ years
`400
`Pregnant females
`280
`Lactating females
`-**~*--*-**~*-~“--~*~-~'~'-=~“rr---*-*-~"*~*****~-——~“~*“~*”~'*--
`
`,
`
`Beneficial Effects
`.
`Folic acid, vitamin B12, and a form of the amino acid methionine known as SAM
`(S—adenosyl—methionine; see Chapter 45) function as ”methyl donors.” They carry
`and donate methyl molecules to facilitate reactions, including the manufact-ure of
`DNA and brain neurotransmitters.
`Much of the benefit of folic acid (along with vitamin B6 and B12) supplementation
`is a result of reducing body concentrations of homocysteine, an intermediate in the
`conversion of the amino acid methionine to cysteine. If a person is relatively deficient
`in folic acid, he or she experiences an increase in homocysteine. This compound has
`been implicated in a variety of conditions, including atherosclerosis and osteoporo-
`sis. Homocysteine most likely promotes atherosclerosis by directly damaging the
`artery and reducing the integrity of the vessel wall. In osteoporosis, elevated homo-
`cysteine levelswlead to a defective bone matrix by interfering with the formation of
`proper collagen (the main protein in bone).
`
`Available Forms
`
`---....
`
`"‘*'-~
`
`V
`
`.
`
`Folic acid is available as folic acid (folate) and folinic acid (5-methyl-tetra~hydrofo1ate).
`In order to utilize folic acid, the body must convert it first to tetrahydrofolate and then
`add a methyl group to form 5—methyl-tetra~hydrofolate (folinic acid). Therefore, sup-
`plying the body with folinic acid bypasses these steps. Folinic acid is the most active
`form of folic acid and is more efficient at raising body stores than folic acid.‘
`
`Principal Uses
`
`Folic acid deficiency or supplementation is a factor in the following health conditions:
`0 Acne
`.
`
`~—-—~——-
`
`0 AIDS
`
`0 Anemia
`
`l2l
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0007
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0007
`
`

`
`VITAMINS
`
`i
`‘fig! 0;
`‘at’,
`g
`0
`
`0
`
`=
`
`5.
`
`Z
`
`1
`
`H5
`
`i
`
`
`
`:3
`.
`
`’
`
`
`
`'
`
`7
`
`4
`
`A
`
`,
`
`I
`
`i
`'
`
`;
`
`_
`_,
`
`l
`_
`
`fl
`.
`
`5
`
`9:3;
`“
`
`n
`
`;
`
`0 Atherosclerosis
`° Cancer
`0 Candidiasis
`0 Canker sores (recurrent)
`0 Cataract
`
`0 Celiac disease
`
`0 Cerebrovascular insufficiency
`0 Cervical dysplasia
`0 Constipation
`0 Crohn’s disease
`0 Diarrhea
`
`0 Epilepsy
`0 Fatigue
`0 Gout
`
`0 Hepatitis
`
`Infertility
`0
`0 Osteoporosis
`0 Neural tube defects
`0 Parkinson's disease
`0 Periodontal disease
`0 Restless legs syndrome
`0 Seborrheic dermatitis
`- Senility
`0 Ulcerative colitis
`E‘Fa‘ 8‘z:.-0 SD539. U):
`
`"U‘E.
`
`(DB(D3.S33::O:1 §*< EE5 :15%E?)--l h‘z: 9.’. 9(D(‘D(D 85:2.5Es’50 S-G
`
`35$
`
`Prevention of Neural Tube Defects
`Neural tube defects refer to a developmental failure affecting the spinal cord or brain
`in the embryonic stageoffetal development. Veryearlyin fetal development, there is
`a ridge ofnerve tissue along theback ofthe embryo. As the fetus develops, this ridge
`becomes the spinal cord, body nerves, and brain. Atthe same time, the bones that
`make up the back gradually surround the spinal cord on all sides. If any part of the
`development process goes awry, many defects can occur. The worst is total lack of
`brain (anencephaly). The most common is spina bifida,\_a defect in which the verte-
`brae do not form a complete ring to protect the spinal cord. In the United States, ap-
`proximately one to two babies per 1,000 births have a neural tube defect. Folic acid
`
`122
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz v. Eli Lilly, Exhibit 1087-0008
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0008
`
`

`
`
`
`
`
`FOLIC ACID
`
`supplementation (400 micrograms per day) in early pregnancy is projected to reduce
`the incidence of neural tube defects by 48 percent to 80 percent.
`The discovery that folic acid can prevent spina bifida and other neural tube de-
`fects has been referred to as one of the greatest discoveries of the last part of the
`twentieth century. Numerous studies have now demonstrated the benefit of folic
`acid supplementation beginning either preconception or very early on in the preg—
`nancy and continued througliout.“ The evidence became so overwhelming that the
`FDA finally had to reverse its previous position, acknowledge the association be—
`tween folic and neural tube defects, and allow folic acid supplements and high folic
`acid-containing foods. Now the FDA claims that ”Daily consumption of folic acid by
`women of childbearing age may reduce the risk of neural tube defects.”
`Concerning this discovery of the link between folic acid deficiency and neural
`tube defects, I have noticed how long it took for obstetricians and other medical doc-
`tors to begin making the recommendation of folic acid supplementation to pregnant
`women. Once it became ”accepted medical practice,” however, obstetricians felt they
`had to do everything possible to make sure that their patients were taking folic
`acid——presumably to prevent a malpractice suit being filed in the event that a child
`happened to be born with a neural tube defect.
`Although obstetricians and other medical doctors claim the protective effect of
`folic acid was not known until 1992 (when the U.S. Public Health Service issued a
`recommendation that all U.S. women of childbearing age capable of becoming preg-
`nant should consume 4OO micrograms of folic acid), the fact of the matter is that folic
`acid deficiency has been linked to neural tube defects for over 30 years. The first
`double-blind studies showing a protective effect of folic acid supplementation were
`performed in the early 1980s.“ It makes one wonder how long it will take the med-
`ical profession to accept other links of nutritional supplementation in the treatment
`and prevention of disease.
`
`1ci~
`: of
`on.
`
`Atherosclerosis
`
`Elevated homocysteine levels are an independent risk factor for developing a heart
`attack, stroke, or peripheral vascular disease. Elevations in homocysteine are found
`in approximately 20 to 40 percent of patients with heart disease?” It is estimated
`that folic acid supplementation (400 micrograms daily) alone would reduce the num-
`ber of heart attacks suffered by Americans each year by 10 percent. Although folic
`acid supplementation (l to 2.5 milligrams daily) on its own lowers homocysteine lev-
`els in many cases, given the importance of vitamin B12 and B6 to proper homocys-
`teine metabolism it simply makes more sense to use all three together.““3
`
`Osteoporosis
`
`Increased homocysteine concentrations in the blood have been demonstrated in
`postmenopausal women and probably play a role in osteoporosis by interfering with
`collagen cross-linking, leading to a defective bone matrix.“"5 Since osteoporosis is
`a loss of both the organic and inorganic phases of bone, the homocysteine theory
`
`123
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0009
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0009
`
`

`
`
`
`VITAMINS
`
`has much validity because it is one of the few that addresses both factors. Folic acid
`supplementation reduces homocysteine levels in postmenopausal women even
`though none of the women were deficient in folic acid by standard laboratory criteria.
`
`Cervical Dysplasia
`Cervical dysplasia is an abnormal condition of the cells of the cervix. It is generally
`regarded as a precancerous lesion and has risk factors similar to those of cervical can-
`cer. It is quite probable that many abnormal Pap smears reflect folate deficiency .
`rather than true dysplasia, especially in women who are pregnant or taking oral con-
`traceptives, because estrogens antagonize folic acid.“'‘9 Although macrocytic ane-
`mia is the most commonly recognized sign of folic acid deficiency, abnormalities in
`the cervical cells are seen many weeks ear1ier.“’I‘7
`Some researchers hypothesize that oral contraceptives interfere with folate metabo-
`lism and, although serum levels may be increased, tissue levels of the cervix may be
`
`dysplasia), while serum levels may be normal or even increased.” Oral contraceptives
`probably stimulate the synthesis ofa molecule that inhibits folate uptake by cells.
`In clinical studies, folic acid supplementation (10 milligrams per day) results in
`improvement or normalization of Pap smears in patients with cervical dysplasia.“"2°
`The rate of normalization for women with untreated cervical dysplasia is typically
`1.3 percent for mild and 0 percent for moderate dysplasia. When patients were
`treated with folic acid, the regression-to~normal rate was observed to be 20 percent in
`one study” and 100 percent in another”. Furthermore, the progression rate of cervi-
`cal dysplasia in untreated patients is typically 16 percent at 4 months (a figure
`
`untreated women ranges from 86 months for patients with very mild dysplasia to 12
`months for patients with severe dysplasia, and ‘improvement is very uncommon.
`Therefore, I would suggest instituting a trial of folate supplementation (along with
`other considerations discussed) in mild-to-moderate dysplasia, with a follow-up Pap
`smear and coloscopy at 3 months. Vitamin B12 supplementation should always ac-
`company folate supplementation.
`
`Depression
`Many psychiatric patients exhibit folic acid deficiency.2“23 Correction of an underly-
`ing folate acid deficiency has brought about remarkable reversal of mental and psy-
`chological symptoms in some patients, especially elderly patients suffering from
`impaired mental function.2"24“23 Folic acid exerts a mild antidepressant effect,“ pre-
`sumably via its function as a methyl donor and increasing the brain content of sero-
`tonin, SAM (S~adenosyl-methionine), and BH4 (tetrahydrobiopterin). I discuss SAM
`in greater detail in Chapter 45. BH4 functions as an essential coenzyme in the activa-
`124
`
`0 _
`,
`7
`
`‘
`
`I
`‘
`,
`rj
`
`II
`
`,
`
`cf
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz v. Eli Lilly, Exhibit 1087-0010
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0010
`
`

`
`-~»
`
`l he acid
`” _ even
`3r“er13-
`
`nerany
`ai Can"
`Sincy
`on"
`:sn.e"
`‘
`In
`
`gab}?
`reg; be
`_
`, 3'
`:1 weal
`ptives
`s.
`1
`'
`;_tf,,_Ԥ,}
`1‘i?e111?e'
`ent in
`« :ervi~
`18:11:
`an e
`
`_
`
`.
`1'“ m
`to 12
`non‘
`with
`
`-Pap
`5 210-
`
`3‘1)’'
`PSY“
`“Om
`Pm’
`em’
`AM
`W3“
`
`FOLIC ACID
`
`j
`a
`
`‘
`
`’
`
`'
`
`‘
`
`-
`
`'
`
`‘I
`
`‘
`
`;
`5"
`
`_
`5
`r
`
`‘
`
`tion of enzymes that manufacture monoamine neurotransmitters like serotonin and
`dopamine from their corresponding amino acids. Patients with recurrent depression
`have reduced BH4 synthesis, probably as a result of low folic acid or SAM levels. Bl-I4
`supplementation produces dramatic results in these patients.29'~°’° Unfortunately, BH4
`is not currently available commercially. However, since folic acid, vitamin B12, and
`vitamin C stimulate Bl-I4 synthesis, it is possible that increasing these vitamin levels
`in the brain may stimulate both BH4 formation and the synthesis of monoamines like
`serotonin.“
`Folic acid supplementation increases methylation reactions in the brain, leading to
`an increase in the serotonin content of the brain. The serotonin~elevating effects are
`undoubtedly responsible for much of the antidepressive effects of folic acid and
`other methyl donors.32‘34 Typically, the dosages used in the clinical studies where
`folic acid has been used as an antidepressant have been very1\igh—15 milligrams to
`50 milligrams. Dosages of folate this high require a doctor's prescription. High-dose
`folic acid therapy is safe (except in patients with epilepsy) and can be as effective as
`antidepressant drugs.“ However, there are other natural measures in this book that
`yield even better results (SAM).
`
`Dosage Ranges
`These are the condition-based dosages I recommend:
`0 For general health and the prevention of atherosclerosis and osteoporosis, 400 mi-
`crograms daily
`0 For the treatment of cervical dysplasia and depression, 10 milligrams daily.
`....,....-re....‘....~a_~.».._~..............................-.,....................................,v‘...........A...........,..........,.....~...t....A..,.....Mum-.... «..—....».~....,..v-... um.‘..,..V.....»_~4.«..~.1«.....4....4..,....-..-...n.....—.«.».»..~.....~»..........»_-.1
`Since the FDA restricts the amount of folic acid available in nutritional supple~
`ments to 400 micrograms, ask your doctor for a prescription when higher
`levels are required.
`ax.........«.....«....u~.....<......_.(.‘.....¢...................~.......y.m....Nuts...»..\,...aw..............................«.....w..4...~.-.~.....~...«...»...,...¢...-...M..--..»........a........-.-..~v,4~..«.~..4«..x;.ua».u.\...«.«..~.».-a.4w..«.«uv.v.»......t....;..\..
`
`Safety Issues
`
`Folic acid supplementation should always include vitamin B12 supplementation
`(400 to 1,000 micrograms daily) because folic acid supplementation can mask an
`underlying vitamin B12 deficiency. The danger is that while the folic acid reverses
`the macrocytic anemia, it does not prevent or reverse the neurological symptoms of a
`Vitamin B12 deficiency. Nerve damage can result that does not respond to vitamin B12
`supplementation.
`Folic acid is well—tolerated. In high dosages (e.g., 5 to 10 milligrams) it may cause
`increased flatulence, nausea, and loss of appetite. High dosage folic acid supplemen-
`tation should be used with extreme caution in epileptics because occasionally it may
`increase seizure activity.
`
`125
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0011
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0011
`
`

`
`
`
`VITAMINS
`
`Interactions
`
`Folic acid works together with vitamin B12, SAM, vitamin B6, and choline. Oral pan-
`creatic extracts may reduce folic acid absorption, so they should be administered
`away from folate supplementation.”
`Estrogens, alcohol, various chemotherapy drugs (especially methotrexate), sul~
`fasalazine (a drug used in the treatment of Crohn’s disease and ulcerative colitis),
`barbiturates, and anticonvulsant drugs all interfere with folic acid absorption or
`function.
`
`126
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz v. Eli Lilly, Exhibit 1087-0012
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0012
`
`

`
`nun-:awu«ova:s...a..................—.-...n.=.....
`
`15
`Muwwm
`
`Cobalamin (Vitamin B12)
`
`
`
`4.-01......as-.»»;.:-u:a.&:§>a'~s‘s—-waits:
`
`_)r‘_‘1 Pan-
`ln1Stered
`
`lte)/ Sul.
`3 colitis),
`Ption or
`
`
`
`Vitamin B12, or cobalamin, was isolated from a liver extract in 1948 and identified as
`the nutritional factor in liver that prevented pernicious anemia, a deadly type of ane-
`mia characterized by large, immature red blood cells. Vitamin B12 is a bright red -crys-
`talline compound because of its high content of cobalt. Vitamin B12 works with folic
`acid in many body processes, including the synthesis of DNA, red blood cells, and
`the insulation sheath (the myelin sheath) that surrounds nerve cells and speeds the
`conduction of the signals along nerve cells. In order to absorb the small amounts of
`vitamin B12 found in food, the stomach secretes intrinsic factor, a special digestive se-
`cretion that increases the absorption of vitamin B12 in the small intestine.
`
`Food Sources
`Vitamin B12 is found in significant quantities only in animals foods. The richest
`sources are liver and kidney, followed by eggs, fish, cheese, and meat (see Table 15.1).
`Strict vegetarians (vegans) ‘are often told that fermented foods like tempeh are ex-
`cellent sources of vitamin B12. However, in addition to tremendous variation of B12
`
`TABLE 15.1 Vitamin Bu Content of Selected Foods, in Micrograms
`per 3 ‘./2-oz. (100-g.) Serving
`
`‘
`
`Blue cheese
`4.0
`Salmon, flesh
`104.0
`Liver, lamb
`Haddock, flesh
`3.0
`Tuna, flesh
`98.0
`Clams
`Flounder, flesh
`2.1
`Lamb
`80.0
`Liver, beef
`Scallops
`2.0
`Eggs
`63.0
`Kidneys, lamb
`Cheddar cheese
`2.0
`Whey, dried
`60.0
`Liver, calf
`Cottage cheese
`1.8
`Beef, lean
`31.0
`Kidneys, beef
`Mozzarella cheese
`1.8
`Edam cheese
`25.0
`Liver, chicken
`Halibut
`1.8
`Swiss cheese
`18.0.
`Oysters
`Perch, filets
`1.6
`Brie cheese
`17.0
`Sardines
`Swordfish, flesh
`Gruyére cheese 1.6
`5.0
`Trout
`......._,....,.._......_........,.....m_._..1_.....-.,.........
`
`
`1.4
`1.3
`1.2
`1.2
`1.0
`1.0
`1.0
`1.0
`1.0
`1.0
`
`127
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0013
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0013
`
`

`
`VITAMINS
`
`
`content in fermented foods, some evidence indicates that the form of B12 in these
`foods is not exactly the form that meets our body requirements and is therefore use-
`less. The same holds true of certain cooked sea vegetables. Although the vitamin B12
`content of these foods is in the same range as beef, scientists do not know how well
`our bodies utilize this form. Therefore, at this time I would recommend that vegetar-
`ians supplement their diets with vitamin B12.
`
`Deficiency Signs and Symptoms
`
`Unlike other water~soluble nutrients, vitamin B12 is stored in the liver, kidney, and
`other body tissues. As a result, signs and symptoms of vitamin B12 deficiency may
`not show themselves until 5 to 6 years of poor dietary intake or inadequate secretion
`of intrinsic factor. The classic deficiency symptom of vitamin B12 deficiency is perni-
`cious anemia. However, a deficiency of vitamin B12 actually affects the brain and ner-
`vous system first.
`A vitamin B12 deficiency results in impaired nerve function, which can cause
`numbness, pins~and-needles sensations, or a burning feeling. It can also cause im-
`paired mental function that in the elderly mimics Alzheimer's disease. Vitamin B12
`deficiency is thought to be quite common in the elderly and is a major cause of de-
`pression in this age group.
`In addition to anemia and nervous system symptoms, a vitamin B12 deficiency can
`also result in a smooth, beefy red tongue and diarrhea. This occurs because rapidly
`reproducing cells such as those that line the mouth and entire gastrointestinal tract
`cannot replicate without vitamin B12. Folic acid supplementation masks this defi-
`ciency symptom.
`Measuring the level in the blood (serum cobalamin) or the level of methylmalonic
`acid in the urine is the best method to determine vitamin B12 deficiency. In addition,
`measuring the level of plasma homocysteine is emerging as a method to determine
`the status of both vitamin B12 and folate. Another test, the Schilling test, is used to de-
`termine whether there is sufficient output of intrinsic factor. The test involves oral
`administration of radioactive vitamin B12 and then measuring the level excreted in
`the urine. Below-normal urinary excretion of the vitamin suggests impaired absorp-
`tion because of lack of intrinsic factor.
`Several investigators have found the level of vitamin B12 declines with age and
`that vitamin. B12 deficiency is found in 3 to 42 percent of persons aged 65 and over.
`Physicians should attempt to diagnose cobalamin deficiency early in the elderly be-
`cause it is easily treatable and, if left untreated, can lead to impaired neurological and
`cognitive function.”
`Researchers recently studied 100 consecutive geriatric outpatients who were seen
`in office~based settings for various acute and chronic medical illnesses; none of these
`outpatients presented symptoms of vitamin B12 deficiency-related diseases like per-
`nicious anemia. In this group, 11 patients had serum cobalamin levels at 148 pmol/ L
`(picomole per liter) or below, 30 patients had levels between 148 and 295 pmol/L,
`and 59 patients had levels above 296 pmol/L. After the initial cobalamin determina-
`tion, the subjects were followed for up to 3 years. The patients with cobalamin levels
`128
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0014
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0014
`
`

`
`COBALAMIN (VITAMIN B12)
`
`below 148 pmol/ L were treated and were not included in the analysis of declining
`cobalamin levels. The average annual serum cobalamin level decline was 18 pmol/ L
`for patients who had higher initial serum cobalamin levels (actual range, from 224 to
`292 pmol/L). For patients with lower initial cobalamin levels, the average annual
`serum cobalamin decline was much higher at 28 pmol/ L.3
`These results indicate that in the elderly the following screen tests for vitamin B12
`have a high cost—to-benefit ratio:45
`
`0 Level of vitamin B12 in the blood (serum cobalamin)
`
`- Urinary excretion of methylmalonic acid
`
`0 Level of homocysteine
`Of these three tests, the urinary methylmalonic acid assay is perhaps the best test
`because it is sensitive, noninvasive, and relativel convenient for the atient. Correc~
`Y
`P
`tion of an underlying vitamin B12 deficiency improves mental function and quality of
`life in these patients quite significantly.
`
`0
`Recommended Dietary Allowance
`Recommended Dietary Allowance of Cobalamin (Vitamin B1,)
`
`
`
`" B12
`W911
`eta”
`
`and
`[gay
`10,“
`.m1_
`'
`“er”
`- .use
`
`im-
`B
`12
`de—
`
`
`
`i
`
`a
`
`:1;
`aft
`“ 1'
`_
`me
`ml
`ne
`{e_
`ml
`in
`
`P"
`
`.
`
`Id
`at.
`e-1
`
`id
`
`-in
`
`se
`r~
`L
`.,
`1-
`.s
`
`'
`
`Group
`
`INFANTS
`Under 6 months
`6~12 months
`
`CHILDREN
`1-3 years
`figears
`—
`years
`YOUNG ADULTS AND Aoums
`
`,
`
`V
`
`‘
`
`Microgrums
`
`0.3
`0.5
`
`0.7
`
`‘
`
`.
`
`2.0
`11+ years
`2.2
`Pregnant females
`2.1
`Lactating females
`“”“‘“““"“‘“”“'”‘”“‘""”””‘“”"'"’“”““”“’““‘“‘““““““‘“"”‘””“‘““”"‘
`
`Beneficial Effects
`
`Vitamin B12, like folic acid, function as a ”methyl donor.” A methyl donor is a com-
`pound that carries and donates methyl‘ groups (a molecule of one carbon and three
`hydrogen molecules) to other molecules, including cell membrane components and
`neurotransmitters. As a methyl donor, vitamin B12 is involved in homocysteine me~
`tabolism and plays a critical role in proper energy metabolism, immune function,
`and nerve function.
`
`129
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz V. Eli Lilly, Exhibit 1087-0015
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0015
`
`

`
`
` VITAMINS
`
`
`
`
` Homocysteine is a factor in the progression of both atherosclerosis and osteoporo-
`sis. In fact, elevations in homocysteine are an independent risk factor for having a
`
`
`
`heart attack Approximately 20 to 40 percent of patients with heart disease exhibit el~
`
`not lower homocysteine levels i
`.
`.
`supple~
`
`
`
`mentation lowers homocysteine levels only if there are adequate levels of vitamin B12
`and B6. Because of the interconnectedness of these three B vitamins, it is best to
`
`
`supplement with all three.“ Folic acid and vitamin B12 supplementation lowers
`homocysteine levels even in individuals with normal vitamin B12, folic acid, and
`
`
`homocysteine Ievels.9
`
`
`
`
`Available Forms
` Vitamin B12 is available in several forms. The most common form is cyanocobalamin;
`however, vitamin B12 is active in only two forms, methylcobalamin and adenosyl—
`cobalamin. Methylcobalamin is the only active form of vitamin B12 available com-
`
`
`
`mercially in tablet form in the United States. While methylcobalamin is active
`
`
`
`
`
`available form.
`
`
`
`Oral versus Injectable
`Although it is popular to inject vitamin B12, injection is not necessary. The oral ad-
`ministration of an appropriate dosage, even in the absence of intrinsic factor, results
`in effective elevations of vitamin B12 in the blood. Most physicians have ignored this
`fact. An editorial entitled ”Oral Cobalamin for Pernicious Anemia, Medicine's Best
`Kept Secret,” which appeared in the January 2, 1991, edition of [AMA (]ourrzal of the
`American Medical Association) states that oral therapy produces reliable and effective
`treatment, even in severe cases of pernicious anemia.“
`In the United States, physicians rarely use oral vitamin B12 therapy despite the fact
`that it is fully (100 percent) effective in the long-term treatment of pernicious anemia.
`
` 130
`
`
`
`
`
`
`
`
`
`
`,.
`i
`
`;.
`"
`
`
`
`
`
`
`
`
`
`
`
`Sandoz Inc. IPR2016-00318
`
`Sandoz v. Eli Lilly, Exhlblt 1087-0016
`
`Sandoz Inc. IPR2016-00318
`Sandoz v. Eli Lilly, Exhibit 1087-0016
`
`

`
`
`
`COBALAMIN (VITAMIN B12)
`
`Let's first discuss the data showing effectiveness with oral administration before dis~
`cussing the dogma cited for injectable administration.
`Almost as soon as scientists isolated vitamin B12 in 1948, companies introduced an
`injectable form. Researchers busily sought an oral alternative. They tried oral prepa-
`rations containing intrinsic factor, but some patients developed antibodies against
`intrinsic factor and, therefore, would not respond.” Other studies soon documented
`that a small but constant proportion of an oral dose of cyanocobalamin was absorbed
`without intrinsic factor through the process of diffusion; therefore, by sufficiently in~
`creasing the dose, they could obtain adequate absorption.13«"‘
`Early studies show that pernicious anemia could be completely controlled with
`doses of cyanocobalamin in the range of 300 to 1,000 micrograms daily.15"“’ The
`largest of these studies described 64 Swedish patients with pernicious anemia (and
`other vitamin B12-deficiency states) who were treated with 1,000 micrograms oral
`cyanocobalamin daily.‘7'“’ In all patients studied over a 3 year period, the researchers
`observed complete normalization of serum levels and liver stores for vitamin B12 as
`well as full clinical remission.
`Despite this research, physicians in the United States do not use oral vitamin B12
`therapy. Why? Education and bias. Medical texts first state that oral vitamin B12 ther-
`apy of pernicious anemia is ”unpredictable,” has poor patient compliance, and is
`more costly. Then after establishing this bias against oral therapy, they state that oral
`cobalamin is effective and can be used when injection therapy is problematic. In a
`survey of internists, 91 percent erroneously believed that vitamin B12 could not be ab-
`sorbed in sufficient quantities without intrinsic factor. Interestingly, 88 percent of
`these doctors also stated that an effective oral vitamin B12 therapy would be useful in
`their practice and further st

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket